ArticleHemaSphere2021

Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms.

Lise Secardin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.